METTL3 and central nervous system cancer: METTL3 downregulation has been shown to reduce the expression of stem cell-specific markers SSEA1, glioma reprogramming factors POU3F2, SOX2, SALL2, OLIG2, neurosphere formation, and the proportion of viable cells.